Search Results - "Lisec, M"
-
1
Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder
Published in The Journal of urology (01-11-2004)“…In this phase 3 trial we assessed the efficacy of solifenacin 5 mg and 10 mg daily in patients with symptoms related to overactive bladder. In addition, we…”
Get more information
Journal Article -
2